Intellectual Property Protection Deteriorating

BMI View: We believe that complying with international intellectual property (IP) law has been a boon for Jordan's domestic pharmaceutical sector and pharmaceutical exports. It is no coincidence that the first country in the region to move towards better IP standards is now the only one with a trade surplus in pharmaceuticals. Although Jordan should address some of the concerns raised in the Pharmaceutical Research and Manufacturers of America (PhRMA)'s Special 301 submission for 2011, this cannot happen while the populist sentiment from the Arab Spring makes such a move politically

To read the full article, please choose one of the following options: